MiMedx Group, Inc. Business Acquisition, Pro Forma Net Income (Loss)
MiMedx Group, Inc. (MDXG) reported Business Acquisition, Pro Forma Net Income (Loss) of $1.32 million for the 12-month period ending 2016-12-31, per its 10-K filed 2020-03-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2020-03-17
- MiMedx Group, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2016-12-31 was -$5.76M, a 145.21% decline year-over-year.
- MiMedx Group, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2016-09-30 was $3.41M, a 19.92% decline year-over-year.
- MiMedx Group, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2016-06-30 was $2.06M, a 58.18% decline year-over-year.
- MiMedx Group, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2016-03-31 was $1.61M, a 44.04% decline year-over-year.
- MiMedx Group, Inc. business acquisition, pro forma net income (loss) for fiscal 2016 was $1.32M, a 94.72% decline from fiscal 2015.
- MiMedx Group, Inc. business acquisition, pro forma net income (loss) for fiscal 2015 was $24.96M.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|
| 2016-12-31 | -$5.76M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | -$2.35M derived: sum of 2 quarters · filed 2020-03-17 | -$293.00K derived: sum of 3 quarters · filed 2020-03-17 | $1.32M 10-K · filed 2020-03-17 | $12.61M 10-K · filed 2017-03-01 |
| 2016-09-30 | $3.41M 10-Q · filed 2016-11-08 | $5.46M derived: sum of 2 quarters · filed 2016-11-08 | $7.07M 10-Q · filed 2016-11-08 | $19.81M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2016-06-30 | $2.06M 10-Q · filed 2016-08-02 | $3.67M 10-Q · filed 2016-08-02 | $16.40M derived: sum of 3 quarters · filed 2017-03-01 | $20.65M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2016-03-31 | $1.61M 10-Q · filed 2016-05-10 | $14.34M derived: sum of 2 quarters · filed 2017-03-01 | $18.60M derived: sum of 3 quarters · filed 2017-03-01 | $23.52M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-12-31 | $12.73M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $16.99M derived: sum of 2 quarters · filed 2017-03-01 | $21.91M derived: sum of 3 quarters · filed 2017-03-01 | $24.96M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $4.25M 10-Q · filed 2016-11-08 | $9.17M derived: sum of 2 quarters · filed 2016-11-08 | $12.23M 10-Q · filed 2016-11-08 | ||
| 2015-06-30 | $4.92M 10-Q · filed 2016-08-02 | $7.97M 10-Q · filed 2016-08-02 | |||
| 2015-03-31 | $2.88M 10-Q · filed 2016-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |